Stockholders' Equity (Details) $ / shares in Units, $ in Thousands		1 Months Ended			12 Months Ended
		Sep. 30, 2021 shares	Aug. 31, 2021 USD ($) $ / shares shares	Aug. 31, 2020 USD ($) $ / shares shares	Dec. 31, 2022 $ / shares shares	Dec. 31, 2021 $ / shares shares	Dec. 31, 2020 USD ($) shares
Class Of Stock [Line Items]
Reverse stock split ratio, description				1-for-8.215
Reverse stock split ratio				0.1217
Net proceeds from initial public offering | $							$ 147,628
Common stock, voting rights					one vote for each share
Common Stock Par or Stated Value Per Share | $ / shares					$ 0.00001	$ 0.00001
OrbiMed Royalty & Credit Opportunities, LP.
Class Of Stock [Line Items]
Issuance of common stock, Shares		221,511
OrbiMed Royalty & Credit Opportunities, LP. | OrbiMed Royalty & Credit Opportunities, LP.
Class Of Stock [Line Items]
Issuance of common stock, Shares		221,511
Common Stock
Class Of Stock [Line Items]
Issuance of common stock, Shares	[1]				8,050	1,270,462	6,151,162
Common Stock | Blackstone Alternative Credit Advisors ("Blackstone")
Class Of Stock [Line Items]
Number of shares sold			1,048,951
Aggregate cash consideration | $			$ 30,000
Price per share (in USD per share) | $ / shares			$ 28.60
Common Stock Par or Stated Value Per Share | $ / shares			$ 0.00001
Common Stock | IPO
Class Of Stock [Line Items]
Issuance of common stock, Shares				6,151,162
Shares issued, price per share | $ / shares				$ 24.00
Net proceeds from initial public offering | $				$ 135,435
Underwriting discounts and commissions and offering expenses | $				$ 12,193
Common Stock | Over-Allotment Option
Class Of Stock [Line Items]
Issuance of common stock, Shares				802,325

[1] Common stock of Harmony Biosciences Holdings, Inc.